Autologus peripheral stem cell transplantation in a patient with diffuse systemic sclerosis: our experience
The diffuse form of systemic sclerosis (SSc) can often lead to a rapidly progressive course with the involvement of the visceral organs which causes a severe prognosis. The 5-years cumulative mortality is between 30 and 60%, depending on the clinic form at the onset. Until now, no drug treatment has...
Saved in:
Main Authors: | F. Giorgetti (Author), M.L. Minnucci (Author), P. Santori (Author), L. Ercoli (Author), M. Rossi (Author), M. Del Papa (Author), G. Morico (Author), P. Squadroni (Author), A. Olivieri (Author), R. Centurioni (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2004-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The treatment of diffuse cutaneous systemic sclerosis with autologous hemopoietic stem cells transplantation (HSCT): our experience on 2 cases
by: A. Tyndall, et al.
Published: (2011) -
Some modifications in transplantation of autologus non -cultured melanocytes-keratinocytes suspension in treatment of segmental and focal vitiligo (Egyptian Experience in Alexandria University)
by: Nagat Sobhy, et al.
Published: (2013) -
Autologous stem cell transplantation in patient with diffuse systemic sclerosis
by: A. Lo Monaco, et al.
Published: (2002) -
A study to compare efficacy of non cultured autologus melanocyte transfer versus punch grafting technique for stable vitiligo patients
by: Ambresh S Badad, et al.
Published: (2022) -
Peripheral nervous system in limited systemic sclerosis
by: D. Melchiorre, et al.
Published: (2011)